TARSUS PHARMACEUTICALS, INC. (TARS) Revenue 2020–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$451.4MFY2025 · since FY2020: $0 → $451.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $451.4M | +146.7% |
| FY2024 | $183.0M | +948.6% |
| FY2023 | $17.4M | -32.4% |
| FY2022 | $25.8M | -54.7% |
| FY2021 | $57.0M | — |
| FY2020 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice